tiprankstipranks
Avidity Biosciences initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyAvidity Biosciences initiated with an Overweight at Cantor Fitzgerald
2M ago
Dyne Therapeutics price target raised to $37 from $33 at Guggenheim
PremiumThe Fly
Dyne Therapeutics price target raised to $37 from $33 at Guggenheim
2M ago
Avidity Biosciences price target raised to $33 from $23 at Chardan
PremiumThe Fly
Avidity Biosciences price target raised to $33 from $23 at Chardan
2M ago
3 Best Stocks to Buy Now, 2/29/2024, According to Top Analysts 
PremiumMarket News3 Best Stocks to Buy Now, 2/29/2024, According to Top Analysts 
2M ago
Avidity Biosciences files to sell 5.075M shares of common stock for holders
PremiumThe Fly
Avidity Biosciences files to sell 5.075M shares of common stock for holders
2M ago
Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
PremiumPress Releases
Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
2M ago
Dyne data validate Avidity Biosciences study, says Wells Fargo
PremiumThe FlyDyne data validate Avidity Biosciences study, says Wells Fargo
4M ago
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
PremiumMarket News
M & A News: Bristol-Myers Squibb (NYSE:BMY) to Buy RayzeBio for $4.1B
4M ago
Avidity Biosciences announces data from Phase 1/2 EXPLORE44 clinical trial
PremiumThe Fly
Avidity Biosciences announces data from Phase 1/2 EXPLORE44 clinical trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100